無料セミナー : 2020年3月13日『世界における腹腔鏡手術用ロボット市場の展望』 DRG社共同開催

TEL: 044-952-0102


Breast Imaging Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 661006
出版日 ページ情報 英文 115 Pages
納期: 2-3営業日
本日の銀行送金レート: 1USD=110.86円で換算しております。
Back to Top
胸部画像の世界市場:成長率、動向および予測分析(2019年~2024年) Breast Imaging Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 115 Pages

世界の胸部画像市場は、乳癌の有病率の増加、乳がんイメージングの分野における技術の進歩、乳癌スクリーニングキャンペーンへの様々な組織からの投資などが主な成長促進要因となっています。 Breast Cancer Now 2018の報告によると、英国では毎年50,000人以上の女性と約350人の男性が乳癌と診断されています。毎月約1,000人の女性が乳癌で亡くなっています。一方、胸部画像診断では、被験者または患者は治療目的で放射線に複数回さらされます。しかし、放射線療法は常に患者の健康に良いとは限りません。その為、胸部検査に関連する間違いと副作用は、市場成長を妨げる主要な要因となっています。



第1章 イントロダクション

  • 調査の成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 乳癌の有病率の増加
    • 胸部画像分野における技術的進歩
    • 乳癌検診キャンペーンへの様々な組織からの投資
  • 市場の阻害要因
    • 放射線被ばくによる弊害のリスク
    • 発展途上国におけるスクリーニング検査の高コスト
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の強さ

第5章 市場のセグメンテーション

  • イメージング技術の種類別
    • マンモグラフィ
    • 乳房用超音波
    • 乳房用MRI
    • バイオマーカー
    • 陽電子放出マンモグラフィ
    • 画像誘導乳房生検
    • その他
  • エンドユーザー別
    • 病院
    • 診断センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業概要
    • 富士フイルムホールディングス
    • GE Healthcare
    • Hologic Inc.
    • General Medical Merate SpA
    • Koninklijke Philips NV
    • Aurora Health Care
    • キヤノン
    • CMR Naviscan Corporation
    • SonoCine、Inc.
    • 東芝
    • Dilon Technologies、Inc.

第7章 市場機会および将来動向

Product Code: 48382

Market Overview

The major factors for the growth of the Breast Imaging market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. According to Breast Cancer Now 2018 report, it was reported that in the UK over 50,000 women and around 350 men are diagnosed with breast cancer every year. Around 1,000 women die from breast cancer every month. On the other hand, in breast imaging procedures the subject or patient is exposed to multiple sets of radiations for therapeutic purposes. However, radiation therapy is not always good for the patient's health. Hence, the errors and side effects associated with breast screening is a major restraining factor for the growth of the market studied.

Scope of the Report

As per the scope, Breast imaging is a subspecialty of diagnostic radiology. It involves a range of imaging procedures with a wide variety of tools and technologies to screen, detect, and diagnose breast cancer. If cancer is detected, these tests help our doctors find the type of cancer, as well as determine the stage and location of cancer.

Key Market Trends

Mammography holds the major share in Global Breast Imaging Market

The mammography segment of the global breast imaging market is growing due to the many initiatives taken for the early detection of breast cancer. For instance, the United States Preventive Services Task Force has developed guidelines for mammography screening. Additionally, the National Cancer Institute conducts and facilitates many organizations to develop their guidelines. Breast cancer is one of the leading causes of death among women. Since mammography is the standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. This is increasing the global demand for mammography. In addition, there have been a number of advancements in the field that prevent over-diagnosis and provide better sensitivity to detect smaller carcinomas. These continuous advancements in this field are expected to augment the mammography segment of global breast cancer screening tests market.

North America Accounts for the Largest Share in Global Breast Imaging Market

The number of cancer patients in North America has witnessed a considerable rise. Prostate and breast cancer are the most prevalent forms of cancer in the region. According to the American Cancer Society, Breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. In the US in 2019, there will be an estimated 268,600 new cases of invasive breast cancer expected to be diagnosed in women along with 62,930 new cases of non-invasive (in situ) breast cancer.

The American Cancer Society is playing a vital role in early research to demonstrate the feasibility of mass screening for breast cancer, joining hands with the National Cancer Institute on the nationwide Breast Cancer Detection Demonstration Project. There are initiatives, such as the United States Preventive Services Task Force (USPSTF), made up of doctors and specialists who are researching ways to prevent diseases or detect them early. These societies are spreading awareness among people regarding the benefits of early breast cancer diagnosis and treatment. These factors, as well as the growing innovations in breast cancer imaging techniques, are expected to drive the global breast imaging market.

Competitive Landscape

Global Breast Imaging Market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products and reducing the side effects of the procedures. Key players present in the market include Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., General Medical Merate SpA, Koninklijke Philips NV among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Breast Cancer
    • 4.2.2 Technological Advancements in the Field of Breast Imaging
    • 4.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns
  • 4.3 Market Restraints
    • 4.3.1 Risk of Adverse Effects from Radiation Exposure
    • 4.3.2 High Cost of Screening Tests in the Developing Countries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Type of Imaging Technique
    • 5.1.1 Mammography
    • 5.1.2 Breast Ultrasound
    • 5.1.3 Breast MRI
    • 5.1.4 Biomarkers
    • 5.1.5 Positron Emission Mammography
    • 5.1.6 Image-guided breast biopsy
    • 5.1.7 Others
  • 5.2 By End Users
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers
  • 5.3 Geography
    • 5.3.1 North America
      • US
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Fujifilm Holdings Corporation
    • 6.1.2 GE Healthcare
    • 6.1.3 Hologic Inc.
    • 6.1.4 General Medical Merate S.p.A.
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Aurora Health Care
    • 6.1.7 Canon Inc.
    • 6.1.8 CMR Naviscan Corporation
    • 6.1.9 SonoCine, Inc.
    • 6.1.10 Toshiba Corporation
    • 6.1.11 Dilon Technologies, Inc.


Back to Top